BRADLEY PHARMACEUTICALS INC
10QSB, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: BRADLEY PHARMACEUTICALS INC, 10QSB, EX-1, 2000-08-11
Next: JUNIPER GROUP INC, 10QSB, 2000-08-11


WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from
Balance Sheet, Cash Flow and Statement of Operations and is qualified in
its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         208,863
<SECURITIES>                                         0
<RECEIVABLES>                                4,289,466
<INVENTORY>                                  2,075,185
<CURRENT-ASSETS>                             7,442,562
<PP&E>                                       1,130,508
<DEPRECIATION>                                 886,987
<TOTAL-ASSETS>                              16,367,035
<CURRENT-LIABILITIES>                        6,074,027
<LT DEBT>                                      824,522
                                0
                                          0
<COMMON>                                    15,603,234
<OTHER-SE>                                  (6,134,748)
<TOTAL-LIABILITY-AND-EQUITY>                16,367,035
<SALES>                                      6,889,047
<TOTAL-REVENUES>                             6,889,047
<CGS>                                        1,854,367
<TOTAL-COSTS>                                1,854,367
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             111,938
<INCOME-PRETAX>                             (4,864,479)
<INCOME-TAX>                                  (377,000)
<INCOME-CONTINUING>                         (4,487,479)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (4,487,479)
<EPS-BASIC>                                      (0.57)
<EPS-DILUTED>                                    (0.57)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission